Success Metrics

Active Trials
8(73%)

Phase Distribution

Ph phase_1
6
55%
Ph phase_3
1
9%
Ph phase_2
4
36%

Phase Distribution

6

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
6(54.5%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
1(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

8

trials recruiting

Total Trials

11

all time

Status Distribution
Active(11)

Detailed Status

Recruiting8
Not yet recruiting3

Development Timeline

Analytics

Development Status

Total Trials
11
Active
8
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 16 (54.5%)
Phase 24 (36.4%)
Phase 31 (9.1%)

Trials by Status

not_yet_recruiting327%
recruiting873%

Recent Activity

8 active trials
Showing 5 of 11
recruitingphase_3

A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma

NCT06618664
not_yet_recruitingphase_2

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

NCT07503639
not_yet_recruitingphase_2

Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

NCT07266025
recruitingphase_1

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

NCT06703177
recruitingphase_1

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

NCT06859775
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06618664Phase 3

A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab or Atezolizumab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma

Recruiting
NCT07503639Phase 2

Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Not Yet Recruiting
NCT07266025Phase 2

Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

Not Yet Recruiting
NCT06703177Phase 1

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors

Recruiting
NCT06859775Phase 1

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

Recruiting
NCT06754930Phase 1

A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC

Recruiting
NCT06778031Phase 2

A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

Recruiting
NCT06465563Phase 2

Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer

Recruiting
NCT06589778Phase 1

A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Recruiting
NCT05444088Phase 1

Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma

Recruiting
NCT06373133Phase 1

SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer

Not Yet Recruiting

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11